Patients on daily pill lost about 17% of body weight in trial Results nearly identical to injectable Wegovy New obesity pill ...

There looks to have been another breakthrough in the world of weight loss drugs, with tests suggesting that a new jab could see patients lose fat without even having to change the food they eat. In ...

The stock market indexes all hit new highs amid a Fed rate cut and an Nvidia-Intel alliance. Tesla stock kept racing.

Positive results from the trial further indicate that the company is poised to win the next battle in the weight loss drug ...

More than 15 million adults in the United States, or about 4.5% of the population, are using weight loss drugs like Ozempic ...

FOR many, fat jabs have done a world of good – dulling hunger pangs and banishing maddening “food noise”, causing pounds to fall away. But weight loss jab users could be at risk ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

The telehealth space is getting a fresh infusion of business thanks to obesity drugs. How Hims & Hers and other stocks are ...

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...

Overall, this study shows that medications like Ozempic, Wegovy, and Mounjaro might help with weight loss not only by ...

Danish multinational pharmaceutical company Novo Nordisk’s obesity drug Wegovy (semaglutide 2.4 mg) cut risk of heart attack, ...

Novo Nordisk has a strong financial position and portfolio of weight-loss and diabetes treatments. See why NVO’s stock dip ...